Jean M. Franchi
CIK 1653053 · Chief Financial Officer · last filed 2026-04-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.42M
Companies
5
Total Filings
42
Lifetime Open-Market Net
-$3.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRON | Chief Financial Officer | 70,590 | $78.28 | $5.53M | -$1.72M | 10 | 2026-04-15 |
| BDSX | Director | 5,407 | $24.86 | $134.4K | $0 | 12 | 2026-01-06 |
| REPL | Chief Financial Officer | 128,748 | $13.67 | $1.76M | -$2.01M | 9 | 2023-05-18 |
| MERRIMACK PHARMACEUTICALS INC (MACK) Delisted | Chief Financial Officer | — | $15.13 | — | $0 | 3 | 2018-12-13 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2017-02-03 |
Recent Filings · Page 2 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-14 | IRON | Sell (S) | −2,000 | -$115.0K | EDGAR |
| 2025-07-10 | IRON | Notice (144) | −2,000 | -$111.7K | EDGAR |
| 2025-06-18 | IRON | Sell (S) | −2,000 | -$104.5K | EDGAR |
| 2025-06-16 | IRON | Notice (144) | −2,000 | -$107.4K | EDGAR |
| 2025-05-22 | BDSX | Grant (A) | — | $0 | EDGAR |
| 2025-04-02 | BDSX | Exer (M) | +26,368 | $0 | EDGAR |
| 2025-02-20 | IRON | Sell (S) | −3,136 | -$171.2K | EDGAR |
| 2025-02-12 | IRON | Grant (A) | +36,000 | $0 | EDGAR |
| 2024-05-23 | BDSX | Grant (A) | — | $0 | EDGAR |
| 2024-02-15 | IRON | Grant (A) | +36,666 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.